Shandong Science ›› 2020, Vol. 33 ›› Issue (6): 34-43.doi: 10.3976/j.issn.1002-4026.2020.06.006
• Pharmacology and Toxicology • Previous Articles Next Articles
HOU Yue1, LI Qiang2, WANG Dai-jie 2, CUI Li 2, ZHENG Xin 1, 3*
1.School of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250014, China; 2.Shandong Analysis and Test Center, Qilu University of Technology(Shandong Academy of Sciences), Jinan 250014, China; 3.Qingdao Haici Medical Group, Qingdao 266033, China
Received:
2020-03-19
Online:
2020-12-09
Published:
2020-12-10
CLC Number:
HOU Yue, LI Qiang, WANG Dai-jie, CUI Li, ZHENG Xin. Mechanisms of the drug pair Astragali Radix-Scutellariae Barbatae Herba in treating lung cancer based on network pharmacology[J].Shandong Science, 2020, 33(6): 34-43.
1 |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer Journal for Clinicians, 2018, 68(6): 394-424.
doi: 10.3322/caac.21492 |
2 |
SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics[J]. CA: A Cancer Journal for Clinicians, 2018, 68(1): 7-30.
doi: 10.3322/caac.21442 |
3 |
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
doi: 10.3760/cma.j.issn.0253-3766.2019.01.008 |
4 |
杨清乐, 刘怀民. 中晚期肺癌治疗策略探讨及中医药优势分析[J]. 世界中西医结合杂志, 2016, 11(5): 725-728.
doi: 10.13935/j.cnki.sjzx.160534 |
5 |
关念波, 刘浩, 林洪生. 肺癌中医药治疗的研究进展及展望[J]. 临床肿瘤学杂志, 2013, 18(3): 264-267.
doi: 10.3969/j.issn.1009-0460.2013.03.017 |
6 | 张星星, 李泽庚. 肺癌中医病因病机探讨[J]. 中华中医药杂志, 2015, 30(10): 3447-3449. |
7 | 郑川, 祝捷, 由凤鸣, 等. 肺癌的中医治法及方药使用规律研究[J]. 四川中医, 2016, 34(1): 217-219. |
8 |
李道睿, 吴皓, 刘浩, 等. 基于信息挖掘技术总结林洪生辨治肺癌的临床用药规律[J]. 中医药导报, 2017, 23(23): 30-34.
doi: 10.13862/j.cnki.cn43-1446/r.2017.23.009 |
9 |
蔡云, 陈远彬, 吴蕾, 等. 基于数据挖掘的刘伟胜治疗肺癌用药规律研究[J]. 河北中医, 2018, 40(8): 1132-1135.
doi: 10.3969/j.issn.1002-2619.2018.08.003 |
10 |
杨冰, 于桂红, 李明雨, 等. 基于“补气固表”探究黄芪黄酮组分抑制C57BL/6荷瘤小鼠肿瘤生长及免疫调节机制研究[J]. 中国中药杂志, 2019, 44(23): 5184-5190.
doi: 10.19540/j.cnki.cjcmm.20191104.401 |
11 |
王雪林, 李杨, 刘丹, 等. 黄芪多糖抑制黄嘌呤氧化酶诱导的肺癌A549细胞自噬并调节自噬相关蛋白的表达[J]. 细胞与分子免疫学杂志, 2019, 35(7): 619-624.
doi: 10.13423/j.cnki.cjcmi.008841 |
12 |
刘小敏, 卢琳琳, 黄艳芳, 等. 黄芪水提物抑制PI3K/Akt通路预防肺癌发生的作用及机制研究[J]. 中草药, 2019, 50(7): 1621-1628.
doi: 10.7501/j.issn.0253-2670.2019.07.019 |
13 |
WANG Q, ACHARYA N, LIU Z W, et al. Enhanced anticancer effects of Scutellaria barbata D. Don in combination with traditional Chinese medicine components on non-small cell lung cancer cells[J]. Journal of Ethnopharmacology, 2018, 217: 140-151.
doi: 10.1016/j.jep.2018.02.020 |
14 |
SHIAU A L, SHEN Y T, HSIEH J L, et al.Scutellaria barbata inhibits angiogenesis through downregulation of HIF-1 α in lung tumor[J]. Environmental Toxicology, 2014, 29(4): 363-370.
doi: 10.1002/tox.21763 |
15 | Lab of Systems Pharmacology.TCMSP:Traditional Chinese Medicine systems pharmacology database and analysis platform[EB/OL].[2019-12-27].http://tcmspw.com/index.php. |
16 | 张洁, 谭初兵, 徐为人. Lipinski五规则的研究进展[J]. 药物评价研究, 2011, 34(6): 451-455. |
17 |
LIU H, WANG J, ZHOU W, et, al. Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice[J]. Ethnopharmacol, 2013, 146(3): 773-793.
doi: 10.1016/j.jep.2013.02.004 |
18 | MDI Biological Laboratory & NC State University .CTD: Comparative toxicogenomics database[EB/OL]. [2019-12-27]. http://ctdbase.org/. |
19 | Weizmann Institute of Science. GeneCards: The Human Gene Database[EB/OL]. [2019-12-27].https://www.genecards.org/. |
20 | Swiss Institute of Bioinformatics & Novo Nordisk Foundation Center Protein Research & European Molecular Biology Laboratory. STRING[EB/OL]. [2019-12-27]. https://string-db.org/. |
21 |
顾浩, 陈寅萤, 王朋倩, 等. 基于熵值的冠心病基因网络模块划分方法评价与模块功能相似度分析[J]. 中国药理学与毒理学杂志, 2018, 32(5): 377-384.
doi: 10.3867/j.issn.1000-3002.2018.05.005 |
22 |
纪立秋. 中医药对90例恶性肿瘤患者中医体质影响研究[J]. 亚太传统医药, 2016, 12(1): 96-98.
doi: 10.11954/ytctyy.201601042 |
23 |
董永彩, 商亚珍. 半枝莲的药理学研究进展[J]. 承德医学院学报, 2009, 26(1): 98-100.
doi: 10.3969/j.issn.1004-6879.2009.01.059 |
24 |
CHO Y Y, YAO K, PUGLIESE A, et al. A regulatory mechanism for RSK2 NH2-terminal kinase activity[J]. Cancer Research, 2009, 69(10): 4398-4406.
doi: 10.1158/0008-5472.can-08-4959 |
25 |
LEE K M, LEE K W, JUNG S K, et al. Kaempferol inhibits UVB-induced COX-2 by suppressing Src kinase activity[J]. Biochemical Pharmacology, 2010, 80(12): 2042-2049.
doi: 10.1016/j.bcp.2010.06.042 |
26 |
HUANG W W, TSAI S C, PENG S F, et al. Kaempferol induces autophagy through AMPK and AKT signaling molecules and causes G2/M arrest via downregulation of CDK1/cyclin B in SK-HEP-1 human hepatic cancer cells[J]. International Journal of Oncology, 2013, 42(6): 2069-2077.
doi: 10.3892/ijo.2013.1909 |
27 |
KANG J W, KIM J H, SONG K, et al. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells[J]. Phytotherapy Research, 2010, 24(S1): S77-S82.
doi: 10.1002/ptr.2913 |
28 |
IMRAN M, RAUF A, SHAH Z A, et al. Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: a comprehensive review[J]. Phytotherapy Research, 2019, 33(2): 263-275.
doi: 10.1002/ptr.6227 |
29 |
TAY K C, TAN L T H, CHAN C K, et al. Formononetin: a review of its anticancer potentials and mechanisms[J]. Frontiers in Pharmacology, 2019, 10: 820.
doi: 10.3389/fphar.2019.00820 |
30 |
李亮亮, 黄金智. 毛蕊异黄酮葡萄糖苷药理作用的研究进展[J]. 海南医学院学报,2020,26(2):156-160.
doi: 10.13210/j.cnki.jhmu.20191223.001 |
31 |
吕凤, 杜倩, 奚鑫, 等. 圣草酚药理作用研究进展[J]. 中草药, 2019, 50(23): 5907-5912.
doi: 10.7501/j.issn.0253-2670.2019.23.036 |
32 |
康宝丽, 陆英, 徐增光. Toll样受体在肺癌中的研究进展[J]. 同济大学学报(医学版), 2015, 36(3): 140-144.
doi: 10.16118/j.1008-0392.2015.03.031 |
33 |
KUTIKHIN A G. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology[J]. Human Immunology, 2011, 72(10): 955-968.
doi: 10.1016/j.humimm.2011.06.003 |
34 |
杨东霞, 项锋钢. HIF-1α在肺癌组织中表达的意义[J]. 青岛大学医学院学报, 2004, 40(1): 39-41.
doi: 10.3969/j.issn.1672-4488.2004.01.014 |
35 |
罗娟, 周晓, 程志祥. FoxO1在非小细胞肺癌中的研究进展[J]. 南京医科大学学报(自然科学版), 2018, 38(8): 1161-1166.
doi: 10.7655/NYDXBNS20180830 |
36 |
胡志英, 朱新江, 陈舒晨, 等. 非小细胞肺癌PI3K/AKT/MTOR信号通路的研究现状与进展[J]. 癌症进展, 2018, 16(6): 671-674.
doi: 10.11877/j.issn.1672-1535.2018.16.06.02 |
|